Literature DB >> 21978879

5-oxoprolinemia causing elevated anion gap metabolic acidosis in the setting of acetaminophen use.

Patil Armenian1, Roy R Gerona, Paul D Blanc, Alan H B Wu, Somnath Mookherjee.   

Abstract

BACKGROUND: Anion gap metabolic acidosis is typically encountered in the emergency department (ED) setting as the result of shock, other endogenous metabolic derangements, or from exogenous toxicants. The differential diagnosis for toxicant-related acidosis (exemplified by common mnemonics) emphasizes acute overdose. CASE REPORT: The case we present manifested an anion gap (AG) metabolic acidosis due to a chronic intoxication: acetaminophen (APAP) overuse over a period of weeks. Lactic acidemia did not account for the AG. In this case, chronic APAP overuse, combined with decreased caloric intake and weight loss, was associated with excess 5-oxoproline (pyroglutamic acid), an organic acid accounting for the AG metabolic acidosis. Overproduction of 5-oxoproline is attributed to depleted glutathione stores, leading to perturbation in the γ-glutamyl cycle. The patient was treated with supportive care and with N-acetylcysteine (NAC). By repleting glutathione, NAC may facilitate the resolution of excess 5-oxoproline.
CONCLUSIONS: The ED differential diagnosis of AG metabolic acidosis in chronic APAP overuse, especially with concomitant nutritional compromise, should include 5-oxoprolinemia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978879     DOI: 10.1016/j.jemermed.2011.06.017

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  7 in total

1.  Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon.

Authors:  L Morgan Nordstrom O'Brien; Michael Hooper; Mark Flemmer; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Acquired 5-oxoproline acidemia successfully treated with N-acetylcysteine.

Authors:  Gregory L Hundemer; Andrew Z Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 3.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 4.  Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective.

Authors:  Toby J Athersuch; Daniel J Antoine; Alan R Boobis; Muireann Coen; Ann K Daly; Lucia Possamai; Jeremy K Nicholson; Ian D Wilson
Journal:  Toxicol Res (Camb)       Date:  2018-03-06       Impact factor: 3.524

5.  Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study.

Authors:  J K Berbee; L A Lammers; C T P Krediet; J C Fischer; E M Kemper
Journal:  Eur J Clin Pharmacol       Date:  2017-08-07       Impact factor: 2.953

6.  5-oxoprolinuria (Pyroglutamic Aciduria) and Metabolic Acidosis: Unraveling the Mystery.

Authors:  Subramanian Senthilkumaran; Florence Benita; Narendra Nath Jena; Sambathkumar Sasikumar; Ponniah Thirumalaikolundusubramanian
Journal:  Indian J Crit Care Med       Date:  2019-07

7.  A case of severe glutathione synthetase deficiency with novel GSS mutations.

Authors:  H Xia; J Ye; L Wang; J Zhu; Z He
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.